Chemoinformaics analysis of beta-Amyrin palmitate
Molecular Weight | 665.144 | nRot | 15 |
Heavy Atom Molecular Weight | 584.504 | nRig | 27 |
Exact Molecular Weight | 664.616 | nRing | 5 |
Solubility: LogS | -4.431 | nHRing | 0 |
Solubility: LogP | 2.052 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 128 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 48 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 80 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 46 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 131.767 |
nHD | 0 | BPOL | 82.8606 |
QED | 0.533 |
Synth | 3.176 |
Natural Product Likeliness | 1.015 |
NR-PPAR-gamma | 0.808 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.013 |
Pgp-sub | 0.005 |
HIA | 0.004 |
CACO-2 | -4.93 |
MDCK | 0.0000265 |
BBB | 0.529 |
PPB | 0.908093 |
VDSS | 0.525 |
FU | 0.0331004 |
CYP1A2-inh | 0.928 |
CYP1A2-sub | 0.767 |
CYP2c19-inh | 0.629 |
CYP2c19-sub | 0.346 |
CYP2c9-inh | 0.554 |
CYP2c9-sub | 0.429 |
CYP2d6-inh | 0.054 |
CYP2d6-sub | 0.458 |
CYP3a4-inh | 0.298 |
CYP3a4-sub | 0.419 |
CL | 6.862 |
T12 | 0.332 |
hERG | 0.162 |
Ames | 0.744 |
ROA | 0.876 |
SkinSen | 0.04 |
Carcinogencity | 0.562 |
EI | 0.014 |
Respiratory | 0.036 |
NR-Aromatase | 0.905 |
Antiviral | Yes |
Prediction | 0.694905 |